Houston, TX USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

MD Anderson, Theraclone Sciences form OncoResponse

OncoResponse, an immuno-oncology antibody discovery company, has been launched jointly by The University of Texas MD Anderson Cancer Center and Theraclone Sciences.
6-Oct-2015 8:00 AM EDT Add to Favorites

MD Anderson’s Allison Wins American Cancer Society Medal of Honor


A career-long fascination with discovering the ins and outs of T cells, our immune system’s tailor-made destroyers of infections and dysfunctional cells, has earned Jim Allison, Ph.D., the American Cancer Society’s 2015 Medal of Honor for Basic...
1-Oct-2015 5:05 PM EDT Add to Favorites

Study Shows New ‘Driver’ to Assess Cancer Patient Survival and Drug Sensitivity


Cancer specialists have long looked at genetic mutations and DNA copy changes to help predict patient survival and drug sensitivity.
1-Oct-2015 12:00 PM EDT Add to Favorites

Everolimus Improves Progression-Free Survival for Patients with Advanced, Nonfuctional Neuroendocrine Tumors of the Lung, Gastrointestinal Tract


In an international Phase III randomized study, everolimus, an inhibitor of the mammalian target of rapamycin (mTOR), has shown to dramatically improve progression-free survival for patients with advanced, nonfunctional neuroendocrine tumors (NET)...
26-Sep-2015 6:05 PM EDT Add to Favorites

Breakthrough Study Demonstrates Survival Advantage with Immune Checkpoint Inhibitor for Advanced Kidney Cancer Patients


For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.
25-Sep-2015 6:05 PM EDT Add to Favorites

MD Anderson Study Identifies Leukemia Tumor Suppressor

A protein-coding gene called hnRNP K has been identified as a tumor suppressor for acute myeloid leukemia (AML), a finding that could be important for investigating how best to target treatment of a blood cancer striking mostly older individuals.
24-Sep-2015 12:00 PM EDT Add to Favorites

MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company

The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC.
15-Sep-2015 12:00 PM EDT Add to Favorites

MD Anderson Immunologist Jim Allison Wins Lasker-Debakey Award


For inventing a completely new way to strike cancer by unlocking a shackled immune system attack, Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, will receive the nation’s highest honor for clinical...
8-Sep-2015 9:00 AM EDT Add to Favorites

Our Experts on Newswise

MD Anderson Study Reveals New Insight Into Tumor Progression


Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Poor Survival Among Colorectal Cancer Patients Tied to Biomarker CSN6


A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

MD Anderson Study Predicts New Hepatitis C Drugs Will Place a Dramatic Financial Strain on the Health Care System


The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

MD Anderson Joins CATCH Global Foundation to Boost Child Health, Prevent Cancer in Later Years

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

MD Anderson Energy Balance Expert Available for Obesity, Cancer Stories

30-Oct-2013 8:10 PM EDT

MD Anderson Obesity and Cancer Expert Researches Food Addiction

30-Oct-2013 8:00 PM EDT

The HPV Vaccine: What Have We Learned?

Expert at The University of Texas M. D. Anderson Cancer Center provide insight to parents based on what we've learned about about the HPV vaccine in the past four years.
12-Jan-2010 3:45 PM EST

M. D. Anderson Offers Guidance on Choosing Tobacco Cessation Products

Whether you smoke three cigarettes or three packs of cigarettes a day, kicking the habit is difficult. Various nicotine replacement products are on the market to make quitting easier. But which product is right for you? Experts from The University...
11-Nov-2009 4:15 PM EST

Our YouTube Videos